XML 44 R33.htm IDEA: XBRL DOCUMENT v3.4.0.3
Stockholders' Equity (Tables)
3 Months Ended
Mar. 31, 2016
Stockholders' Equity Note [Abstract]  
Schedule of common stock activity
Summary of common stock activity was as follows:
 
 
Shares
 
 
 
Outstanding December 31, 2015
 
41,110,127

Issuance of common stock - option exercises
 
237,202

Issuance of restricted common stock
 
405,977

Outstanding March 31, 2016
 
41,753,306

Range of warrant prices per share for shares under warrants and the weighted average contractual life
At March 31, 2016 and December 31, 2015, the range of warrant prices per share for common stock underlying warrants and the weighted average contractual life was as follows:
March 31, 2016
 
Number of
Warrants
 
Weighted Average Exercise Price Per Share
 
Weighted Average Remaining Contractual Life
 
Number of
Warrants
Exercisable
 
Weighted Average Price Per Share
Common Stock
 
751,779

 
$
10.30

 
1.08
 
751,779

 
$
10.30

 
December 31, 2015
 
Number of
Warrants
 
Weighted Average Exercise Price Per Share
 
Weighted Average Remaining Contractual Life
 
Number of
Warrants
Exercisable
 
Weighted Average Price Per Share
Common Stock
 
751,779

 
$
10.30

 
1.33
 
751,779

 
$
10.30


Schedule of activity under all stock option plans
Stock option activity under all stock option plans was as follows:
 
 
Number of
Options
 
Weighted
Average
Exercise Price
per Share
Outstanding December 31, 2015
 
5,248,329

 
$
5.56

Granted
 

 

Exercised
 
(237,202
)
 
3.48

Expired
 
(20,652
)
 
10.41

Cancelled/Forfeited
 
(29,413
)
 
9.23

Outstanding March 31, 2016
 
4,961,062

 
$
5.62

Total vested and exercisable
 
4,298,947

 
$
4.84

Assumptions used to estimate the fair value of options at date of grant
The fair value of options at date of grant was estimated using the Black-Scholes option pricing model, based on the following assumptions:
 
 
 
Three Months Ended March 31,
 
 
 
2016
 
2015
Risk-free interest rate
 
 
N/A
 
1.37% - 1.67%
Expected term (in years)
 
 
N/A
 
5.47 - 6.45
Dividend yield
 
 
N/A
 
—%
Expected volatility
 
 
N/A
 
50.00%
Summary of stock-based compensation expense
The following is a summary of stock-based compensation expense (in thousands):
 
 
 
Three Months Ended March 31,
 
 
2016
 
2015
Cost of revenues
 
$
61

 
$
110

Sales and marketing
 
251

 
210

Research and development
 
301

 
254

General and administrative
 
331

 
514

 
 
$
944

 
$
1,088